Speaker illustration

Doctor Roberta Bursi

'S-Hertogenbosch (Netherlands (The))

Dr. Bursi is a global biopharmaceutical professional specialized in Computational Modelling and Simulation (CM&S) methods, and their applications in the pharma and medical devices industry. She has obtained her PhD in Computational Chemistry at the University of Southern California, USA. Dr. Bursi has matured twenty-two years of career in multinational pharma industries like NV Organon, Schering-Plough, Merck, and Co. and Grünenthal where she has built a powerhouse of knowledge and experience across all stages of drug R&D and Registration. She is a certified Project Management Professional and has authored over thirty scientific papers in major journals, has delivered over fifty lectures and is inventor of six patents. Dr. Bursi is currently Vice President R&D at InSilicoTrials Technologies. The company’s mission is to expand the use of CM&S in healthcare by providing web-based, cloud-based technological solutions for R&D of medical products and Point-of-Care.

A web-based tool for the early identification and real time assessment of drug-induced proarrhythmic and torsade de pointes safety risk

Event: ESC Congress 2020

Topic: Cardiotoxicity of Drugs

Session: Pharmacology and Pharmacotherapy ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk